What does MOMS mean in HOSPITALS
MOMS is an acronym that stands for Management of Myelomeningocele Study. It is a large, multicenter study that was conducted to investigate the long-term outcomes of children with myelomeningocele (MMC). MMC is a birth defect that occurs when the spinal cord fails to close properly during pregnancy. This can lead to a variety of physical and developmental problems, including paralysis, incontinence, and learning disabilities.
MOMS meaning in Hospitals in Medical
MOMS mostly used in an acronym Hospitals in Category Medical that means Management of myelomeningocele study
Shorthand: MOMS,
Full Form: Management of myelomeningocele study
For more information of "Management of myelomeningocele study", see the section below.
MOMS Study Design
The MOMS study was conducted at 12 centers in the United States and Canada. It enrolled over 1,000 children with MMC who were born between 1996 and 2000. The children were followed for up to 10 years after birth.
MOMS Study Results
The MOMS study found that children with MMC have a variety of long-term health problems. These problems include:
- Mobility problems: Most children with MMC have some degree of paralysis in their legs. This can make it difficult to walk, run, and play.
- Incontinence: Many children with MMC have difficulty controlling their bladder and bowels. This can lead to social problems and embarrassment.
- Learning disabilities: Children with MMC are more likely to have learning disabilities than children without MMC. This can make it difficult to succeed in school.
- Other health problems: Children with MMC are also more likely to have other health problems, such as seizures, hydrocephalus, and spina bifida.
MOMS Study Conclusions
The MOMS study provides valuable information about the long-term outcomes of children with MMC. The study's findings can help doctors and parents make better decisions about the care of children with MMC.
Conclusion
MOMS is an important study that has helped to improve the care of children with myelomeningocele. The study's findings have shown that children with MMC have a variety of long-term health problems. However, these problems can be managed with early intervention and ongoing care.
Essential Questions and Answers on Management of myelomeningocele study in "MEDICAL»HOSP"
What is the Management of Myelomeningocele Study (MOMS)?
MOMS is a landmark clinical trial that compared two surgical approaches for repairing myelomeningocele, a birth defect involving the incomplete closure of the spinal cord. The study evaluated the long-term outcomes of early surgery versus delayed surgery.
What were the key findings of the MOMS study?
MOMS found that early surgical repair of myelomeningocele, performed within 48 hours of birth, significantly improved the child's motor function and reduced the risk of complications such as hydrocephalus and Chiari II malformation.
Why is early surgical intervention important for myelomeningocele?
Early surgery can prevent further damage to the spinal cord and neural tissues. It also allows for the insertion of a shunt to treat hydrocephalus, a condition where fluid accumulates in the brain.
What are the potential risks and benefits of myelomeningocele surgery?
Potential risks include infection, bleeding, and nerve damage. However, the benefits of early surgery outweigh the risks, as it can significantly improve the child's long-term functional outcomes.
Who should be involved in the decision-making process for myelomeningocele surgery?
The decision of whether to proceed with early surgery should be made in collaboration with a multidisciplinary team, including the child's parents, a pediatric neurosurgeon, and other specialists.
What are the ongoing implications of the MOMS study?
MOMS has established early surgical repair as the standard of care for myelomeningocele. Ongoing research continues to focus on optimizing surgical techniques, improving outcomes, and developing new therapies for children with this condition.
MOMS also stands for: |
|
| All stands for MOMS |